Arkolith/Insider Trading/WHWK/Form 4

Lennon David James

CHIEF EXECUTIVE OFFICER, DirectorWhitehawk Therapeutics, Inc. (WHWK) · full profile →Form 4 · filed Apr 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 1, 2025Grant(A)776K—$0776K
Apr 1, 2025Grant(A)776K—$0776K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-010076) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML